16142BRT-DA01-301OpenexPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's DiseaseBRT-DA01-301 NCT06944522IndustrialAdultTreatmentOtherPagan, FernandoGeorgetown University Medical Center : Hannah Locke; Lombardi Comprehensive Cancer Center : Hannah LockeGUMC Neurology; GUMC PFS16547Hannah LockeHannah Lockehml61@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">&copy; 2026 Advarra, Inc.</a>